February 23, 2026
FDA proposes new system for approving customized drugs and therapies for rare diseases
Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the pharmaceutical industry has long considered unprofitable.
TL;DR
- Federal health officials proposed a new system.
- The proposal aims to spur development of customized treatments.
- This targets hard-to-treat diseases, including rare genetic conditions.
- These conditions were previously considered unprofitable by the pharmaceutical industry.
Continue reading the original article